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INTRODUCTION
Primary tumors of the heart are rare, with an incidence
between 0.0017% and 0.19% in unselected patients at
autopsy. Approximately 75% of the tumors are benign,
and nearly half of them are myxomas (1). Atrial myxoma is
the most common benign cardiac neoplasm, and its origin
has been ascribed to a multipotential mesenchymal cell (2).
Myxomas commonly occur between the third and sixth
decades of life and are three times more frequent in women
(3). There are two distinctive forms of the tumors: solid and
ovoid myxomas and soft and papillary myxomas. Solid
tumors are more likely to present with symptoms of
congestive heart failure (CHF), while papillary tumors are
more likely to embolize to the cerebral and other peripheral
vessels (4). At the time of diagnosis, 92% of the patients have
symptoms of CHF (5). Atrial myxoma may mimic valvular
heart disease, cardiac insufficiency, cardiomegaly, bacterial
endocarditis, disturbances of ventricular and supraventri-
cular rhythm, syncope, and systemic or pulmonary embo-
lism (3). The purpose of this paper is to present a case report
of atrial myxoma mimicking severe mitral valve stenosis at
cardiac auscultation and the importance of echocardiograpy
in the diagnosis.
CASE DESCRIPTION
A 77-year-old Caucasian man presented at the Emergency
Care Unit with a six-month history of congestive heart
failure and in funcional class III, according to the New York
Heart Association (NYHA) criteria. He had no previous
history of diabetes, arterial hypertension, or ischemic co-
ronary disease. The physical examination disclosed dis-
tended neck veins, rales at the lung base, and hepatomegaly.
Cardiac auscultation revealed a loud first heart sound and
diastolic rumble resembling mitral valve stenosis. Chest
radiography showed a normal cardiac silhouette image,
enlarged hilar shadows and moderate right-sided pleural
effusion. The electrocardiogram showed a regular sinus
rhythm with a nonspecific repolarization alteration. The
transthoracic echocardiogram showed an image of a large
pediculate mass of 5.5 mm64.0 mm in the left atrium in his
greater diameters, restricting transmitral diastolic blood
flow, and an atrium-ventricular pressure gradient of
11 mmHg (Figure 1). This mass was attached to the inferior
edge of the fossa ovalis. Left ventricular function was
normal, and the right ventricular diameter was 3.2 cm. His
systolic pulmonary artery pressure was 100 mmHg. The
patient was referred for cardiac surgery. The adopted tech-
nique was a biatrial approach. The intraoperative findings
included a mass, and anatomopathologic analysis confirmed
that it was an atrial myxoma. Two days after surgery, an
echodopplercardiogram showed an important reduction in
systolic pulmonary artery pressure to 30 mmHg. Five years
later, an echocardiogram showed no mass in the left atrial
chamber.
DISCUSSION
This case report showed an atrial myxoma mimicking
mitral valve stenosis. The diagnosis was made by echo-
cardiogram, which disclosed a huge mass obstructing the
left atrial blood flow. Heart valve disease is one of the
differential diagnoses of atrial myxomas. The clinical
findings of cardiac tumors are characterized by the triad
of embolism, intracardiac obstruction, and constitutional
findings. Congestive heart failure is the most common
clinical presentation, followed by neurologic and syste-
mic embolic events. Embolic events more frequently
affect the cerebral arteries, including the retinal arteries.
Embolization into visceral, renal, or coronary arteries has
also been reported and can affect nearly 29% of patients (3).
Although the large majority of myxomatous emboli are
cerebral, it is possible for atrial myxomas to embolize and
implant in other locations in the visceral and peripheral
arterial circulation. Ectopic myxoma implants have been
described in other unusual locations, including the skin,
the skeleton, and the small bowel. Intracardiac obstruction
with impaired filling of the left or right ventricle causes
subsequent dyspnea, recurrent pulmonary edema, right-
heart failure or even syncope or sudden death (6). Three
fourths of myxomas are located in the left atrium (7).
General or constitutional manifestations, such as fatigue,
fever, weight loss, night sweats, arthralgia, and laboratory
abnormalities, such as elevation of C-reactive protein,
anemia, and the erythrocyte sedimentation rate, can also
occur.
Mitral valve obstruction caused by atrial myxoma repre-
sents an important hemodynamic consequence leading to
symptoms of congestive heart failure, pulmonary hyperten-
sion, syncope, and sudden death. Clinicopathologic correla-
tions showed that mitral stenotic effects occurred when the
tumor diameter exceeded 5 cm (8). Echodopplercardiography
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is the most important method for the differential diagnosis
with primary valve disease. Moreover, it can estimate the
transvalve gradient. It has been reported that patients with
left atrial myxomas have reduced transmitral blood flow.
Nevertheless, only large myxomas can resemble severe mitral
stenosis. The differential diagnosis of an intracardiac mass
encompasses benign and malignant primary heart tumors,
metastatic tumors and thrombi. Eletrocardiographic findings
are unspecific. The cardiac rhythm is usually normal. Chest X-
ray may reveal an enlargement of the left atrium and some
signs of pulmonary hypertension and congestion. Calcifi-
cations, which make the tumor visible on routine radio-
graphic examination, are unusual. Computed tomography
and magnetic resonance imaging can differentiate tissue
composition, making it possible to identify the nature of the
mass. The preoperative diagnosis of cardiac tumors could be
performed correctly utilizing angiography, echocardiogra-
phy, or both. Coronary angiography is reserved for older
patients who may have coexisting coronary artery disease
(9).
Controversy remains regarding the optimal operative
approach to atrial myxomas. The biatrial approach has been
advocated to achieve the most complete tumor excision and
assess the possibility of tumors in the right atrium (10).
Other options include minimally invasive thoracoscopic
surgery and the use of robotic technology. Surgical excision
of the tumor appears to be curative, and recurrence is rare,
as shown five years later in an echocardiogram of this
patient.
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Figure 1 - Giant obstructive left atrial mixoma (arrows) in systole and diastole.
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